We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vascular Access Device Reduces Needle Stick Injuries

By HospiMedica International staff writers
Posted on 21 Jul 2015
A novel technology reduces the need for puncture blood draws from peripheral veins in the intensive care unit (ICU) setting. More...


The disposable Tiva device is designed to allow newly placed peripheral intravenous (PIV) catheters to be momentarily repurposed to draw blood from patients, thereby reducing the need for extra venipuncture procedures. The device—which comes in 20 and 22 gauge sizes—is comprised of an inner tube with a plunger, a proximal flexible tube with female luer, and an outer barrel with a male luer. The male luer attaches to the PIV system, while the female luer attaches to a blood transfer device or syringe, from which a blood sample is then collected.

The device is transiently attached to a PIV catheter line and is activated by advancing the plunger, which advances a small polymer cannula through the PIV catheter and into the vessel. Blood is then drawn using standard vacuum tubes; after the requisite number of tubes is filled, the cannula is retracted by pulling the plunger back to its resting position, exiting the PIV. It is then detached from the PIV line and discarded. The Tiva device is a product of Velano Vascular (San Francisco, CA, USA), and has received the European Community CE mark of approval.

“A fundamental benefit of this technology is reducing the 'pin cushion effect', in which hospitalized patients are 'stuck' several times daily to obtain blood tests. Oftentimes, the draw procedure is plagued by multiple failed attempts,” said Eric Stone, co-founder and CEO of Velano Vascular. “Starting with the basic premise of replacing an antiquated technology—phlebotomy needles, which date back centuries—to dramatically improve patient care has led us to an incredible business opportunity that benefits patients, practitioners and hospitals alike.”

Related Links:

Velano Vascular



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.